These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2531375)

  • 1. Memory effect of caerulein and its analogs in active and passive avoidance responses in the rat.
    Itoh S; Takashima A; Igano K; Inouye K
    Peptides; 1989; 10(4):843-8. PubMed ID: 2531375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(1):105-10. PubMed ID: 3714527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic projection to the central amygdala mediates the facilitatory effect of CCK-8US and caerulein on memory in rats.
    Winnicka MM; Wiśniewski K
    Pharmacol Res; 1999 Jun; 39(6):445-50. PubMed ID: 10373247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of cholecystokinin, beta-endorphin, and their antagonists on passive avoidance behavior in rats.
    Itoh S; Katsuura G; Takashima A
    Can J Physiol Pharmacol; 1987 Nov; 65(11):2260-4. PubMed ID: 2966663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasoactive intestinal peptide (VIP) causes memory impairment in passive avoidance responding of the rat.
    Takashima A; Maeda Y; Itoh S
    Peptides; 1993; 14(5):1067-71. PubMed ID: 8284258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bilateral 6-OHDA lesions to the hippocampus attenuate the facilitatory effect of CCK-8 us and caerulein on memory in rats.
    Winnicka MM; Wisniewski K
    Pharmacol Res; 2000 Mar; 41(3):347-53. PubMed ID: 10675288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-Hydroxydopamine infusions into the structures of mesolimbic dopaminergic system alter the memory enhancing effect of CK-8US and caerulein in rats.
    Winnicka MM; Hryniewicz A; Bialuk I; Wiśniewski K
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():148-9. PubMed ID: 11820580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholecystokinin-related peptides, after systemic or central administration, prevent carbon monoxide-induced amnesia in mice.
    Maurice T; Hiramatsu M; Kameyama T; Hasegawa T; Nabeshima T
    J Pharmacol Exp Ther; 1994 May; 269(2):665-73. PubMed ID: 8182534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passive avoidance deficit following intracerebroventricular administration of cholecystokinin tetrapeptide amide in rats.
    Katsuura G; Itoh S
    Peptides; 1986; 7(5):809-14. PubMed ID: 3797342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ceruletide and haloperidol on the hypothalamo-pituitary beta-endorphin system and brain beta-endorphin contents in the rat: with special reference to effects of ceruletide in chronically haloperidol-treated rats.
    Hagino Y; Okuwa M; Moroji T
    Neuropeptides; 1991 Jan; 18(1):1-14. PubMed ID: 2046884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T; Fekete M; Telegdy G
    Acta Physiol Acad Sci Hung; 1981; 58(4):269-74. PubMed ID: 6291322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of sulfated and nonsulfated cholecystokinin octapeptides on electroconvulsive shock-induced retrograde amnesia after intracerebroventricular administration in rats.
    Kádár T; Penke B; Kovács K; Telegdy G
    Neuropeptides; 1984 Mar; 4(2):127-35. PubMed ID: 6325992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.
    Van Ree JM; Gaffori O; De Wied D
    Eur J Pharmacol; 1983 Sep; 93(1-2):63-78. PubMed ID: 6138272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bifemelane hydrochloride (MCI-2016) on experimental amnesia (passive avoidance failure) in rodents.
    Tobe A; Yamaguchi T; Nagai R; Egawa M
    Jpn J Pharmacol; 1985 Oct; 39(2):153-61. PubMed ID: 4087564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholecystokinin octapeptide increases passive avoidance latencies in rats.
    Deupree D; Hsiao S
    Physiol Behav; 1988; 42(2):203-5. PubMed ID: 3368541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of cerulein on memory impairment induced by protein synthesis inhibitors in rats.
    Itoh S; Takashima A; Maeda Y
    Peptides; 1992; 13(5):1007-12. PubMed ID: 1480506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment with caerulein protects against memory impairment induced by protein kinase C inhibitors in the rat.
    Takashima A; Yokota T; Maeda Y; Itoh S
    Peptides; 1991; 12(4):699-703. PubMed ID: 1788133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cholecystokinin octapeptide and ceruletide on release of acetylcholine from cerebral cortex of the rat in vivo.
    Magnani M; Mantovani P; Pepeu G
    Neuropharmacology; 1984 Nov; 23(11):1305-9. PubMed ID: 6098846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin receptors and memory: a radial maze study.
    Harro J; Oreland L
    Pharmacol Biochem Behav; 1993 Mar; 44(3):509-17. PubMed ID: 8451255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of caerulein on decreased latency of passive avoidance response in rats treated with NMDA receptor antagonists.
    Takashima A; Maeda Y; Itoh S
    Peptides; 1990; 11(6):1263-7. PubMed ID: 1982352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.